"We've completed our restructuring and emerged stronger than ever," said Sumit Kapur, Chief Executive Officer of Zapata Quantum. "This financing is a strong vote of confidence from long-term, fundamentals-oriented investors and positions us to scale at a critical moment as quantum computing transitions from technical progress to transformational real-world value creation."
"Zapata stands out for its commitment to technical rigor, deep portfolio of foundational IP, and proven experience helping enterprises advance in their quantum journey," said Jeff Huber, General Partner of Triatomic Capital. "We're proud to support Zapata's growth as it continues to demonstrate leadership in translating quantum advantage into quantum utility."
Leadership in Quantum Value Creation
Since emerging from Harvard's Quantum Computing Lab in 2017, Zapata has led foundational work advancing real-world quantum applications across Fortune 500 enterprises and the public sector, spanning high-value domains including cryptography, pharmaceuticals, finance, materials discovery, and defense.
A recent example of Zapata's work highlighting quantum-enabled drug discovery was selected as one of Nature Biotechnology's top 10 scientific papers of 2025, and featured as the journal's December 2025 cover. The study, co-authored with Dana-Farber Cancer Institute, University of Toronto, and Insilico Medicine, focused on targeting the KRAS mutation in cancer therapy—serving as a proof point of Zapata's capabilities and quantum computing's ...
